Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?
- PMID: 37727016
- PMCID: PMC10509509
- DOI: 10.1111/1753-0407.13469
Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?
References
-
- Joshi GP, Abdelmalak BB, Weigel WA, et al. American Society of Anesthesiologists Consensus‐Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon‐Like Peptide‐1 (GLP‐1) Receptor Agonists. Downloaded August 19, 2023 from https://www.asahq.org/about‐asa/newsroom/news‐releases/2023/06/american‐...
-
- Mariani G, Boni G, Barreca M, et al. Radionuclide gastroesophageal motor studies. J Nucl Med. 2004;45(6):1004‐1028. - PubMed
-
- Jensterle M, Ferjan S, Ležaič L, et al. Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity. Diabetes Obes Metab. 2023;25(4):975‐984. - PubMed
-
- Bloomgarden ZT. Basal insulin or longacting GLP‐1 receptor agonists‐making the right choice. Lancet Diabetes Endocrinol. 2014;2(6):439‐441. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources